Travoprost 0.004% in Pediatric Glaucoma Patients

Update Il y a 4 ans
Reference: EUCTR2012-001324-34

Woman and Man

  • | Country :
  • -
  • | organs :
  • -
  • | Specialty :
  • -

Extract

The primary objective of this study is to demonstrate that the IOP-lowering efficacy of Travoprost Ophthalmic Solution, 0.004% (preserved with POLYQUAD) is noninferior to Timolol Ophthalmic Solution (0.5% or 0.25%) in pediatric glaucoma patients.


Inclusion criteria

  • Pediatric glaucoma;elevated intraocular pressure